Pyrimidine compound and pharmaceutical use thereof
申请人:HANMI PHARM. CO., LTD.
公开号:US10280154B2
公开(公告)日:2019-05-07
Provided are a pyrimidine compound represented by Formula 1, a method of preparing the same, and a pharmaceutical use of the pyrimidine compound for the prevention or treatment of cancer.
[EN] PYRIMIDINE COMPOUND AND PHARMACEUTICAL USE THEREOF<br/>[FR] COMPOSÉ PYRIMIDINE ET SON UTILISATION PHARMACEUTIQUE<br/>[KO] 피리미딘 화합물 및 그의 의약 용도
申请人:HANMI PHARM IND CO LTD
公开号:WO2018139903A1
公开(公告)日:2018-08-02
본 발명은 화학식 1의 피리미딘 화합물, 그 화합물의 제조방법, 및 암의 예방 또는 치료를 위한 그 화합물의 의약 용도에 관한 것이다.
WO2007/18941
申请人:——
公开号:——
公开(公告)日:——
PYRIMIDINE COMPOUND AND PHARMACEUTICAL USE THEREOF
申请人:HANMI PHARM. CO., LTD.
公开号:US20190031643A1
公开(公告)日:2019-01-31
Provided are a pyrimidine compound represented by Formula 1, a method of preparing the same, and a pharmaceutical use of the pyrimidine compound for the prevention or treatment of cancer.